Wikidata

(Q64709909)

English

Phase II Study of TKI258 in Advanced Urothelial Carcinoma

clinical trial

In more languages

Statements

title
A Phase II Multi-center, Non-randomized, Open Label Study of TKI258 in FGFR3 Mutated and FGFR3 Wild Type Advanced Urothelial Carcinoma (English)
0 references
sponsor
Novartis
0 references
country
Austria
0 references
Canada
0 references
Germany
0 references
Italy
0 references
Spain
0 references
Taiwan
0 references
United Kingdom
0 references
start time
March 2010
0 references
end time
April 2012
0 references
number of participants
44
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64709909&oldid=1857973360"